ResMed (RMD) – Globe Newswire
-
Richmond Minerals Inc. – New Drill Targets Identified in the Cyril Knight Zone at Ridley Lake Project, Swayze Greenstone Belt, Ontario, and Closing of Non-Brokered Private Placement
-
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
-
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sle
-
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
-
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
-
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
-
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
-
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
-
ResMed Chief Administrative Officer and Global General Counsel to Retire
-
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
-
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
-
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
-
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
-
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
-
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
-
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
-
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
-
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
-
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
-
ResMed Announces Participation in the Bank of America Global Healthcare Conference
-
ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference
-
Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
-
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
-
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
-
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
-
ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care
-
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
-
ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference
-
ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
-
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
-
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
-
ResMed Announces Leadership Change
-
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
-
ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
-
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
-
ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
-
ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
-
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
-
Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems
-
ResMed Announces Participation in the Citi Healthcare Conference
-
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
-
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
-
ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
-
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
-
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
-
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
-
ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
-
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
-
Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
-
ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
Back to RMD Stock Lookup
